CRISPR & Gene Expression

CRISPR & Gene Expression CRISPR technologies have transformed biological research by providing powerful tools to modify, regulate, and study gene function with unprecedented precision. From genome-wide functional screening to targeted gene activation, repression, and knockout, CRISPR-based approaches empower researchers to uncover gene function, identify therapeutic targets, investigate disease mechanisms, and accelerate drug discovery. Boca Scientific offers a comprehensive portfolio of CRISPR and gene expression products designed to support genomics research across academic, biotechnology, pharmaceutical, and translational research laboratories. These solutions include pooled lentiviral CRISPR libraries, gene activation and repression systems, screening tools, and supporting reagents that enable researchers to perform both large-scale and targeted studies of gene function. Functional genomic screening is now an essential approach for identifying genes involved in disease pathways, therapeutic resistance, cellular differentiation, immune regulation, and other complex biological processes. CRISPR pooled screening technologies allow thousands of genetic perturbations to be evaluated simultaneously within a single experiment, providing researchers with an efficient method to identify genes that influence specific phenotypes. Cellecta's lentiviral CRISPR libraries are designed for high-complexity pooled screening applications and are available in plasmid and ready-to-use lentiviral formats, enabling rapid implementation of genome-wide or focused screening projects. In addition to CRISPR-based screening, pooled lentiviral RNAi libraries remain valuable tools for gene silencing studies and functional genomics research. RNA interference (RNAi) technologies enable targeted knockdown of gene expression and are widely used for pathway analysis, target validation, synthetic lethality studies, and investigations where partial suppression of gene activity is preferred over complete gene knockout. Together, CRISPR and RNAi screening platforms provide complementary approaches for understanding gene function and biological mechanisms.